tiprankstipranks
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (PL:SVE)
:SVE
Poland Market
SVE
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.
RESEARCH TOOLSreports
Want to see PL:SVE full AI Analyst Report?

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (SVE) Cash flow

0 Followers

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Cash Flow

PL:SVE's free cash flow for Q4 2025 was zł2.51M. For the 2025 fiscal year, PL:SVE's free cash flow was decreased by zł7.30M and operating cash flow was zł11.94M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
zł 7.22Mzł 13.73Mzł -5.34Mzł 2.95Mzł -3.28M
Investing Cash Flow
zł -27.82Mzł -25.89Mzł -72.90Mzł -26.97Mzł -4.49M
Financing Cash Flow
zł 21.50Mzł 10.75Mzł 53.33Mzł 36.82Mzł 20.22M
End Cash Position
zł 1.67Mzł 760.00Kzł 2.17Mzł 27.09Mzł 14.30M
Free Cash Flow
zł -20.81Mzł -28.11Mzł -117.95Mzł -33.81Mzł -21.71M
Currency in PLN

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Cash Flow